Prothena Corporation PLC
NASDAQ:PRTA
Prothena Corporation PLC
NASDAQ:PRTA
Price:
22.93 USD
4.04%
Market Closed
Updated:
May 4, 2024
Prothena Corporation PLC
Revenue
|
Prothena Corporation PLC
Revenue Peer Comparison
Comparables:
ALKS
AMRN
M
MURA
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Prothena Corporation PLC
NASDAQ:PRTA
|
Revenue
$91.4m
|
CAGR 3-Years
367%
|
CAGR 5-Years
147%
|
CAGR 10-Years
61%
|
|
|
Alkermes Plc
NASDAQ:ALKS
|
Revenue
$1.7B
|
CAGR 3-Years
17%
|
CAGR 5-Years
9%
|
CAGR 10-Years
11%
|
|
|
Amarin Corporation PLC
NASDAQ:AMRN
|
Revenue
$277.5m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
1%
|
CAGR 10-Years
23%
|
|
M
|
Mural Oncology PLC
NASDAQ:MURA
|
Revenue
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Prothena Corporation PLC
Revenue Breakdown
Breakdown by Geography
Prothena Corporation PLC
Prothena Corporation PLC
Not Available
Breakdown by Segments
Prothena Corporation PLC
Prothena Corporation PLC
|
Total Revenue:
91.4m
USD
|
|
Collaboration Revenue:
91.3m
USD
|
|
Revenue From License And Intellectual Property:
50k
USD
|
See Also
What is Prothena Corporation PLC's Revenue?
Revenue
91.4m
USD
91.4m
USD
Based on the financial report for Dec 31, 2023, Prothena Corporation PLC's Revenue amounts to 91.4m USD.
What is Prothena Corporation PLC's Revenue growth rate?
Revenue CAGR 10Y
61%
61%
Over the last year, the Revenue growth was 70%. The average annual Revenue growth rates for Prothena Corporation PLC have been 367% over the past three years , 147% over the past five years , and 61% over the past ten years .
You don't have any saved screeners yet
